Toggle navigation
Home
About BioMark
About Us
BioMark Technology
Publications & Scientific Posters
Awards and Achievements
Strategic Collaborations
Cancer Education Videos
Oncology Platform
Biomark SSAT1 Assay
BioMark Metabolic Panel
Investor Relations
Stock Quote
News Releases
Investment Highlights
Corporate Presentations and Communication
Bio-Stream Diagnostics
Bio-Stream Spectral Test
Recent Posts
Info & Contact
News Releases
« Back to News
BioMark Diagnostics Receives Clearance from Health Canada to Commence Clinical Trial with Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer
September 9, 2015
Sept 9thBioMark Diagnostics Receives Clearance from Health Canada
(PDF)
———————————————
<
BioMark Diagnostics Announces Progress in Assay Validation for Clinical Sample Analysis
BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung Cancer
Dr. James Bond of Surrey Memorial Hospital to act as Principal Investigator
>